Felipe K Hurtado
3PUBLICATIONS
12CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Mar 07, 2022
Phase I Study of Taminadenant (PBF509/NIR178), an Adenosine 2A Receptor Antagonist, with or without Spartalizumab (PDR001), in Patients with Advanced Non-Small Cell Lung Cancer.Alberto A Chiappori, Ben Creelan, Tawee Tanvetyanon
|Jan 29, 2022
ASCEND-7: Efficacy and Safety of Ceritinib Treatment in Patients with ALK-Positive Non-Small Cell Lung Cancer Metastatic to the Brain and/or Leptomeninges.Laura Q M Chow, Fabrice Barlesi, Erin M Bertino
|Jan 04, 2021
Effect of ceritinib on the pharmacokinetics of coadministered CYP3A and 2C9 substrates: a phase I, multicenter, drug-drug interaction study in patients with ALK + advanced tumors.Felipe K Hurtado, Filippo de Braud, Javier De Castro Carpeño
Pageof 1
Frequent Collaborators
1 joint publications
Morten Mau-Sorensen
1 joint publications
Laura Q M Chow
1 joint publications
Erin M Bertino
1 joint publications
Martin J van den Bent
1 joint publications
Heather A Wakelee
1 joint publications
Margarita Majem
1 joint publications
Pilar Garrido
1 joint publications
Dong-Wan Kim
1 joint publications
Alberto A Chiappori
1 joint publications
Ben Creelan
